LEUKAEMIA
Clinical trials for LEUKAEMIA explained in plain language.
Never miss a new study
Get alerted when new LEUKAEMIA trials appear
Sign up with your email to follow new studies for LEUKAEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immune cell therapy takes on Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new treatment called EBNK-001, which uses donor immune cells (natural killer cells) to fight advanced solid tumors. About 83 adults with cancers like lung, breast, or colorectal cancer that have not responded to standard treatments will receive these cells alon…
Matched conditions: LEUKAEMIA
Phase: PHASE1, PHASE2 • Sponsor: Essen Biotech • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
AI and lab tests aim to find best cancer treatment in two weeks
Knowledge-focused Recruiting nowThis study is testing a new approach called xDRIVE that combines lab tests on tumor samples with artificial intelligence to suggest personalized cancer treatments. It involves 210 Florida patients with cancers that have come back or not responded to standard therapy, including ch…
Matched conditions: LEUKAEMIA
Phase: NA • Sponsor: First Ascent Biomedical Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 05:24 UTC
-
AI tutors aim to boost clinical trial enrollment in blood cancer patients
Knowledge-focused Recruiting nowThis study tests whether an AI-powered chatbot can help people with blood cancers (like leukemia or lymphoma) better understand clinical trials and feel more willing to join one. About 196 patients will be randomly assigned to receive either standard information or AI-assisted ed…
Matched conditions: LEUKAEMIA
Phase: NA • Sponsor: Zhongnan Hospital • Aim: Knowledge-focused
Last updated May 20, 2026 11:54 UTC